Status:
COMPLETED
Functional Validation of Lactobacillus Containing Oral Tablet
Lead Sponsor:
National Cheng-Kung University Hospital
Collaborating Sponsors:
Grape King Bio Ltd.
Conditions:
Periodontal Disease
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
Dental caries and periodontal disease are the two most common diseases in dentistry. Caries was caused by the acidic environment produced through the interaction of oral flora (biofilm) and fermentabl...
Detailed Description
The following parameters will be collected and analyzed: periodontal pocket depth, the gingival inflammation index, the plaque index, and the ratio of Firmicutes/ Bacteroidetes/Streptococcus mutans/Po...
Eligibility Criteria
Inclusion
- 20\~65 years old
- At least 20 teeth except wisdom teeth
Exclusion
- Smoking habits
- Oral cancer or other serious oral diseases.
- Pregnancy
- Severe chronic diseases
- Coagulation diseases
- Long-term or regular use of medication (anti-epileptics, antihistamines, anti-inflammatory, sedatives, tranquilizers, analgesics, Chinese herbs)
- Allergy to test products
Key Trial Info
Start Date :
October 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 29 2022
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04873505
Start Date
October 30 2020
End Date
April 29 2022
Last Update
June 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan